XNAS: MLTX
MoonLake Immunotherapeutics (Class A) Live Stock Price Today, Share Analysis and Chart
about
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...
Read More
17.01
-0.55
(-3.13%)
680.8K
XNAS Volume
XNAS 05 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for MoonLake Immunotherapeutics (Class A) is on 12 May 2026 for the purpose of MoonLake Immunotherapeutics First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
MoonLake Immunotherapeutics (Class A) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..